Work Here?
Industries
AI & Machine Learning
Healthcare
Company Size
201-500
Company Stage
Growth Equity (Venture Capital)
Total Funding
$283.6M
Headquarters
San Francisco, California
Founded
2016
Viz.ai focuses on healthcare technology, using artificial intelligence to improve patient care coordination. Its main product, the Viz.ai Intelligent Care Coordination Platform, enhances communication among medical teams by providing real-time alerts and mobile image viewing, particularly for neurovascular conditions like ischemic stroke. The platform stands out by integrating with existing electronic health records and operates on a subscription model, ensuring patient data security through HIPAA compliance. The goal is to enhance patient outcomes and hospital efficiency while reducing physician burnout.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$283.6M
Above
Industry Average
Funded Over
8 Rounds
Health, dental, & vision insurance
401K retirement plan
Generous vacation time
Paid parental leave
Monthly wellness days
Professional development stipend
DELRAY BEACH, Fla., Dec. 19, 2024 /PRNewswire/ -- The global artificial intelligence in healthcare market, valued at US$10.31 billion in 2023, is forecasted to grow at a robust CAGR of 49.1%, reaching US$14.92 billion in 2024 and an impressive US$164.16 billion by 2030. The market growth is primarily driven by the increase in the chronic diseases such as heart disease, stroke, diabetes, and cancer subsequently putting significant pressure on healthcare service providers to optimize their operations. Moreover, technological advancements in machine learning algorithms, cloud computing, data analytics, and other sophisticated technologies is largely driving the market growth. Companies are updating their product portfolio to incorporate artificial intelligence into their offerings. For instance, GE Healthcare, Cognizant, and many more have upgraded their Artificial Intelligence (AI) in healthcare capabilities to enhance overall healthcare experience
Viz.ai collaborates with Microsoft to advance AI-powered clinical workflows and better patient care.
Viz.ai will launch 13 AI models on the cloud-based platform designed to provide support for patients with acute and nonacute diseases, such as stroke, hemorrhage, pulmonary embolism, and aortic dissection.
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received the 2024 Prix Galien USA Award for Best Digital Health Solution for its Viz HCM(TM) (Hypertrophic Cardiomyopathy) module.
Viz.ai partners with Cleerly in the name of ai-based CCTA evaluations.
Find jobs on Simplify and start your career today
Industries
AI & Machine Learning
Healthcare
Company Size
201-500
Company Stage
Growth Equity (Venture Capital)
Total Funding
$283.6M
Headquarters
San Francisco, California
Founded
2016
Find jobs on Simplify and start your career today